{"id":"524f82a9-f06c-4e86-855a-610bab61ecda","name":"Covidien","slug":"covidien","description":"Covidien was a medical device company acquired by [Medtronic](/companies/medtronic) in 2015 for $49.9B. Products included surgical instruments, vascular devices, and respiratory care. Now integrated into Medtronic's portfolio.","status":"subsidiary","founded":0,"hq":"Dublin, Ireland","hqLat":53.3493795,"hqLng":-6.2605593,"hqGeocodedAt":"2026-08-05T14:25:35.989Z","hqAddress":null,"hqPrecision":null,"website":"https://www.medtronic.com/covidien","fundingTotal":null,"type":"hardware","roles":[],"reviewStatus":"reviewed","heatIndex":50,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.medtronic.com/","title":"Medtronic Covidien","date_accessed":"2026-06-24"}],"keyFacts":[{"label":"HQ","value":"Dublin, Ireland"},{"label":"Focus","value":"Medical device company"},{"label":"Stage","value":"Acquired by Medtronic"},{"label":"Technology","value":"Surgical and robotic-assist technologies"},{"label":"Status","value":"Acquired by Medtronic 2015 ($49.9B)"},{"label":"Products","value":"Surgical instruments, vascular devices, respiratory care"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-25T00:29:50.047Z","updatedAt":"2026-08-21T17:37:22.362Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/covidien","url":"https://registry.deploy.report/companies/covidien","name":"Covidien","description":"Covidien was a medical device company acquired by [Medtronic](/companies/medtronic) in 2015 for $49.9B. Products included surgical instruments, vascular devices, and respiratory care. Now integrated into Medtronic's portfolio.","identifier":"524f82a9-f06c-4e86-855a-610bab61ecda","address":"Dublin, Ireland","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}